Haemophilus influenzae Serotyping via PCR Primer Design
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting Haemophilus influenzae, particularly serotyping, are subjective and prone to interpretation errors, and there is a need for improved detection and monitoring due to changes in disease-causing serotypes and vaccine efficacy.
Innovation Solution
The use of specific primers and probes targeting genes such as hpd, acsB, bcsB, ccsD, dcsE, ecsH, and Hif bexD for PCR-based detection and serotyping of Haemophilus influenzae, allowing for rapid and sensitive identification of the bacteria in biological samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If slide agglutination serotyping (SAST) is used for Hi serotyping, then serotype identification can be performed, but the reading and scoring are subjective and difficult to interpret when agglutination reaction is weak or when there is variability in sensitivity or specificity of reagents
Solution Approach 1:
The patent replaces the mechanical/visual interpretation system of slide agglutination with a molecular biology system (PCR) that provides objective, quantifiable results. The mechanical mixing and visual scoring of agglutination reactions is substituted with nucleic acid amplification and detection, which yields binary positive/negative results that are not subject to human interpretation variability.
Solution Approach 2:
The patent introduces nucleic acid sequences as an intermediary between the bacteria and the detection system. Instead of directly observing bacterial agglutination, the method detects specific DNA sequences that are unique to each serotype, providing an objective molecular marker that eliminates subjectivity in interpretation.
2Measurement precision
If PCR-based detection with specific primers is used, then detection sensitivity and specificity are improved, but the method complexity increases compared to traditional serotyping
Solution Approach 1:
The patent segments the detection process into distinct molecular components: specific forward and reverse primers for each serotype, separate PCR reaction mixes, and individual detection steps. This segmentation allows for high precision through serotype-specific targeting while managing complexity by organizing the method into modular, standardized components that can be systematically applied.
3Ease of operation
If traditional serotyping methods are used, then the process is simpler to perform, but the results are subjective and prone to interpretation errors
Solution Approach 1:
The PCR-based method is designed to be self-differentiating through serotype-specific primers that automatically amplify only the correct target sequence. The system serves itself by using the inherent genetic differences between serotypes to generate distinct amplification products, eliminating the need for subjective interpretation while maintaining procedural straightforwardness through standardized protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a robust and specific method for detecting Haemophilus influenzae, including non-typeable strains, with high sensitivity and specificity, enabling effective monitoring and diagnosis of infections.
Implementation Method 1
a forward primer that hybridizes to a first region within a gene of Haemophilus influenzae, and a reverse primer that hybridizes to a second region within said gene
Implementation Method 2
producing an amplification product by amplifying a Haemophilus influenzae nucleotide sequence using a forward primer and a reverse primer under conditions suitable for a polymerase chain reaction
Data Source
AI summary
A process for detecting Haemophilus influenzae nucleic acid in a sample includes producing an amplification product by amplifying a Haemophilus influenzae nucleotide sequence and measuring the amplification product to detect Haemophilus influenzae in the sample. Some embodiments allow direct serotype determination in a single step assay. Also provided are reagents and methods for detecting and distinguishing Haemophilus influenzae from other infectious agents. A kit is provided for detecting and quantifying Haemophilus influenzae in a sample.